Panitumumab-Associated Drug-Induced Immune Thrombocytopenia in a Patient with Colorectal Cancer

Severe thrombocytopenia is a rare adverse event of panitumumab. Here, we report the first patient with metastatic colorectal cancer who developed severe thrombocytopenia, diagnosed as panitumumab-associated drug-induced immune thrombocytopenia (DITP). A clinical diagnosis of DITP can be obtained by...

Descripción completa

Detalles Bibliográficos
Autores principales: Takamizawa, Shigemasa, Shoji, Hirokazu, Hirano, Hidekazu, Izutsu, Koji, Yamamoto, Shun, Iwasa, Satoru, Honma, Yoshitaka, Okita, Natsuko, Takashima, Atsuo, Kato, Ken, Boku, Narikazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983597/
https://www.ncbi.nlm.nih.gov/pubmed/33776687
http://dx.doi.org/10.1159/000512821

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983597/
https://www.ncbi.nlm.nih.gov/pubmed/33776687
http://dx.doi.org/10.1159/000512821

Ejemplares similares